MetaCap

Translational Development Acquisition Corp. Company Profile

NASDAQ: TDACFinancial ServicesShell CompaniesUSD

10.82+0.02 (+0.19%)

Market open · Delayed 15 min · as of Oct 9, 1:40 PM ET

Translational Development Acquisition at a glance

Translational Development Acquisition Corp. (NASDAQ: TDAC) is a Shell Companies company in the Financial Services sector headquartered in New York, NY. Translational Development Acquisition is led by Mr. Michael M. B. Hoffman J.D.. The company's shares have traded publicly since 2025.

At a market capitalization of $208.9 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0001926599, which identifies the company's filings on EDGAR.

Summary generated from market data by MetaCap's automated system. Methodology

What does Translational Development Acquisition do?

Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.

Business description based on the company's public filings.

Company information

Legal name
Translational Development Acquisition Corp.
Ticker
NASDAQ: TDAC
Industry
Shell Companies
CEO
Mr. Michael M. B. Hoffman J.D.
Headquarters
52 E. 83rd Street, New York, NY, United States
Phone
917 979 3072
IPO year
2025
Market cap
$208.88M
SEC CIK
0001926599
Latest annual report
10-K/A · May 11, 2026

Companies similar to Translational Development Acquisition

Related